← Leaderboards
Leonardo V. Riella
Brigham And Women'S Hospital
$2,097,044
Attributed
$2,097,044
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $442.2K · FY2019–23$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,097,044 · 1
By mechanism
R01$2,097,044 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Reza Abdi$32,829,278
- Jamil Azzi$5,263,824
- David A. Hafler$48,350,086
- Rachael Ann Clark$20,922,246
- Stefan Gunther Tullius$7,768,739
Others in their field
Other Emerging Leaders on “Effective Therapy”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$69,114,853
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Yunda Huang · Fred Hutchinson Cancer Center$51,679,442
Research focus
Effective TherapyAdaptive ImmunityDrug UsageAcuteAllograftingAntigen PresentationAntigen ProcessingDown-RegulationAgonistBindingBiological Response ModifiersBiologyCd86 GeneCell MaturationCellsClinicAntigen-Specific T CellsAdoptive Cell TransfersConfocal MicroscopyDendritic Cell ActivationDendritic CellsDesignDoseEffector T Cell
Grant awards (5)
Role of Siglec-E in Regulating Alloimmunity$411,000
R01 · FY2023 · AI · contact PI
Role of Siglec-E in Regulating Alloimmunity$411,000
R01 · FY2022 · AI · contact PI
Role of Siglec-E in Regulating Alloimmunity$434,120
R01 · FY2021 · AI · contact PI
Role of Siglec-E in Regulating Alloimmunity$398,737
R01 · FY2020 · AI · contact PI
Role of Siglec-E in Regulating Alloimmunity$442,187
R01 · FY2019 · AI · contact PI